These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8061797)

  • 1. Development of transient thyroid disease and reaction during treatment of chronic hepatitis C with interferon.
    Kodama T; Katabami S; Kamijo K; Katanuma A; Yamashita K; Azuma N; Tamaki T; Yachi A
    J Gastroenterol; 1994 Jun; 29(3):289-92. PubMed ID: 8061797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An episode of silent thyroiditis in a patient with chronic thyroiditis and papillary adenocarcinoma following alpha interferon treatment for hepatitis C.
    Katabami S; Kamijo K; Kodama T; Fujisawa Y; Katanuma A; Yachi A
    Endocr J; 1993 Jun; 40(3):311-6. PubMed ID: 7920883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic hepatitis: a prospective study.
    Mazziotti G; Sorvillo F; Stornaiuolo G; Rotondi M; Morisco F; Ruberto M; Cioffi M; Amato G; Caporaso N; Gaeta GB; Carella C
    J Endocrinol Invest; 2002; 25(7):624-30. PubMed ID: 12150338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy.
    Marazuela M; García-Buey L; González-Fernández B; García-Monzón C; Arranz A; Borque MJ; Moreno-Otero R
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):635-42. PubMed ID: 8759175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of r-interferon alpha administration on hypothalamus-pituitary-thyroid axis in chronic hepatitis.
    Falaschi P; D'Urso R; Proietti A; Martocchia A; Pastore R; Angelucci L
    Life Sci; 1997; 60(1):43-50. PubMed ID: 8995531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient Hypothyroidism and Autoimmune Thyroiditis in Children With Chronic Hepatitis C Treated With Pegylated-interferon-α-2b and Ribavirin.
    Serranti D; Indolfi G; Nebbia G; Cananzi M; D'Antiga L; Ricci S; Stagi S; Azzari C; Resti M;
    Pediatr Infect Dis J; 2018 Apr; 37(4):287-291. PubMed ID: 28953189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment.
    Carella C; Mazziotti G; Morisco F; Manganella G; Rotondi M; Tuccillo C; Sorvillo F; Caporaso N; Amato G
    J Clin Endocrinol Metab; 2001 May; 86(5):1925-9. PubMed ID: 11344186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible primary hypothyroidism with blocking or stimulating type TSH binding inhibitor immunoglobulin following recombinant interferon-alpha therapy in patients with pre-existing thyroid disorders.
    Chen FQ; Okamura K; Sato K; Kuroda T; Mizokami T; Fujikawa M; Tsuji H; Okamura S; Fujishima M
    Clin Endocrinol (Oxf); 1996 Aug; 45(2):207-14. PubMed ID: 8881454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirin.
    Danilovic DL; Mendes-Correa MC; Chammas MC; Zambrini H; Marui S
    Clinics (Sao Paulo); 2011; 66(10):1757-63. PubMed ID: 22012048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithyroid peroxidase antibody and development of silent thyroiditis during interferon-alpha 2a treatment of chronic hepatitis C.
    Wada M; Shimoyama T; Hamada A; Fukuchi M
    Am J Gastroenterol; 1995 Aug; 90(8):1366-7. PubMed ID: 7639264
    [No Abstract]   [Full Text] [Related]  

  • 11. Case report: silent thyroiditis developed during alpha-interferon therapy.
    Kamikubo K; Takami R; Suwa T; Kawase Y; Shiroko J; Kametani M; Tokimitsu N; Sakata S
    Am J Med Sci; 1993 Sep; 306(3):174-6. PubMed ID: 8128980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thyroid dysfunction in patients with chronic hepatitis C pre and post treatment with interferon].
    Martín-Vivaldi R; Nogueras F; Quintero D; Espinosa MD; López de Hierro M; Suárez JF; González A
    Rev Esp Enferm Dig; 1996 Jul; 88(7):480-4. PubMed ID: 8924326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological markers of autoimmunity in renal transplant patients before and after alpha-interferon therapy for chronic hepatitis C.
    Rostaing L; Oksman F; Izopet J; Baron E; Cisterne JM; Hoff M; Abbal M; Durand D
    Am J Nephrol; 1996; 16(6):478-83. PubMed ID: 8955758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy.
    Fernandez-Soto L; Gonzalez A; Escobar-Jimenez F; Vazquez R; Ocete E; Olea N; Salmeron J
    Arch Intern Med; 1998 Jul; 158(13):1445-8. PubMed ID: 9665354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal study of antibodies against thyroid in patients undergoing interferon-alpha therapy for HCV chronic hepatitis.
    Carella C; Amato G; Biondi B; Rotondi M; Morisco F; Tuccillo C; Chiuchiolo N; Signoriello G; Caporaso N; Lombardi G
    Horm Res; 1995; 44(3):110-4. PubMed ID: 7590640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Painless thyroiditis occurring during long-term treatment with interferon alfa in a patient with chronic active hepatitis C.
    Uchida K; Matsui A; Nakano S; Kigoshi T; Morimoto S
    South Med J; 1996 Jan; 89(1):81-3. PubMed ID: 8545699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of autoantibodies and the risk of autoimmune thyroid disease in children with chronic hepatitis C virus infection treated with interferon-alpha.
    Gehring S; Kullmer U; Koeppelmann S; Gerner P; Wintermeyer P; Wirth S
    World J Gastroenterol; 2006 Sep; 12(36):5787-92. PubMed ID: 17007043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Natural history of dysthyroidism during interferon treatment of chronic hepatitis C].
    Mekkakia-Benhabib C; Marcellin P; Colas-Linhart N; Castel-Nau C; Buyck D; Erlinger S; Bok B
    Ann Endocrinol (Paris); 1996; 57(5):419-27. PubMed ID: 8991106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of interferon alpha therapy with thyroid function tests in the management of hepatitis C: a case report.
    Gill G; Bajwa H; Strouhal P; Buch HN
    J Med Case Rep; 2016 Sep; 10(1):253. PubMed ID: 27632981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study on anti-T3 and anti-T4 autoantibodies found in two sisters with juvenile hypothyroidism due to Hashimoto's thyroiditis: II. The effect of treatment with L-thyroxine].
    Nakamura S; Fushimi K; Kamikubo K; Sakata S; Yasuda K; Okuyama M; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1982 Dec; 58(12):1527-43. PubMed ID: 6897780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.